The membranotropic regions of the endo and ecto domains of HIV gp41 envelope glycoprotein

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 1, 2006, Pages 111-123

  Moreno, Miguel R ^a   Giudici, Marcela ^a   Villalaín, José ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

gp41; HIV; Membrane fusion

Indexed keywords

GLYCOPROTEIN; PEPTIDE LIBRARY; PHOSPHOLIPID; VIRUS PROTEIN; GLYCOPROTEIN GP 41; MEMBRANE FUSION PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ARTIFICIAL MEMBRANE; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; LIPID COMPOSITION; MEMBRANE RUPTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; VIRUS STRAIN; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT;

LENTIVIRUS;

AMINO ACID SEQUENCE; CELL MEMBRANE; HIV ENVELOPE PROTEIN GP41; HUMANS; MEMBRANE FUSION PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PHOSPHOLIPIDS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 33646672410     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.01.007     Document Type: Article

References (55)

1. Gallo S.A., Finnegan C.M., Viard M., Raviv Y., Dimitrov A.S., Rawat S.S., Puri A., Durell S., and Blumenthal R. The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614 (2003) 36-50
2. Eckert D.M., and Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70 (2001) 777-810
3. Earp L.J., Delos S.E., Park H.E., and White J.M. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285 (2004) 25-66
4. Markovic I., and Clouse K.A. Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention. Curr. HIV Res. 2 (2004) 223-234
5. Dimitrov A.S., Xiao X., Dimitrov D.S., and Blumenthal R. Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes. J. Biol. Chem. 276 (2000) 30335-30341
6. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
7. Cheung L., McLain L., Hollier M.J., Reading S.A., and Dimmock N.J. Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion. J. Gen. Virol. 86 (2005) 131-138
8. Hollier M.J., and Dimmock N.J. The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function. Virology 337 (2005) 284-296
9. Andreassen H., Bohr H., Bohr J., Brunak S., Bugge T., Cotterill R.M., Jacobsen C., Kusk P., Lautrup B., Petersen S.B., Saermark T., and Ulrich K. Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods. J. Acquir. Immune Defic. Syndr. 3 (1990) 615-622
10. Kliger Y., and Shai Y. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers. Biochemistry 36 (1997) 5157-5169
11. Miller M.A., Garry R.F., Jaynes J.M., and Montelaro R.C. A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res. Hum. Retroviruses 7 (1991) 511-519
12. Chanh T.C., Dreesman G.R., Kanda P., Linette G.P., Sparrow J.T., Ho D.D., and Kennedy R.C. Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO J. 5 (1986) 3065-3071
13. Chen S.S., Lee S.F., and Wang C.T. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41. J. Virol. 75 (2001) 9925-9938
14. Epand R.M. Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta 1614 (2003) 116-121
15. Peisajovich S.G., and Shai Y. Viral fusion proteins: multiple regions contribute to membrane fusion. Biochim. Biophys. Acta 1614 (2003) 122-129
16. Contreras L.M., Aranda F.J., Gavilanes F., González-Ros J.M., and Villalaín J. Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism. Biochemistry 40 (2001) 3196-3207
17. Dimitrov A.S., Rawat S.S., Jiang S., and Blumenthal R. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Biochemistry 42 (2003) 14150-14158
18. Ghosh J.K., and Shai Y. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion. J. Mol. Biol. 292 (1999) 531-546
19. Kliger Y., Peisajovich S.G., Blumenthal R., and Shai Y. Membrane-induced conformational change during the activation of HIV-1 gp41. J. Mol. Biol. 301 (2000) 905-914
20. Miyauchi K., Komano J., Yokomaku Y., Sugiura W., Yamamoto N., and Matsuda Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J. Virol. 79 (2005) 4720-4729
21. Moreno M.R., Pascual R., and Villalaín J. Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan. Biochim. Biophys. Acta 1661 (2004) 97-105
22. Pascual R., Moreno M.R., and Villalaín J. A peptide pertaining to the loop-segment of HIV gp41 binds and interacts with model biomembranes. Implications on the fusion mechanism. J. Virol. 79 (2005) 5142-5152
23. Peisajovich S.G., and Shai Y. SIV gp41 binds to membranes both in the monomeric and trimeric states: consequences for the neuropathology and inhibition of HIV infection. J. Mol. Biol. 311 (2001) 249-254
24. Peisajovich S.G., Epand R.F., Pritsker M., Shai Y., and Epand R.M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry 39 (2000) 1826-1833
25. Peisajovich S.G., Samuel O., and Shai Y. The F1 protein of paramyxoviruses has two fusion peptides: implications for the mechanism of membrane fusion. J. Mol. Biol. 296 (2000) 1353-1365
26. Sackett K., and Shai Y. The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion. Biochemistry 41 (2002) 4678-4685
27. Suárez T., Nir S., Goñi F.M., Sáez-Cirión A., and Nieva J.L. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Lett. 477 (2000) 145-149
28. Suárez T., Gallaher W.R., Agirre A., Goñi F.M., and Nieva J.L. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J. Virol. 74 (2000) 8038-8047
29. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., and Wimley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 (1997) 426-430
30. Kuiken C., Foley B., Hahn B., Marx P., McCutchan F., Mellors J., Wolinsky S., and Korber B. HIV Sequence Compendium 2001 (2001), Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM
31. Hope M.J., Bally M.B., Webb G., and Cullis P.R. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 812 (1985) 55-65
32. Böttcher C.S.F., Van Gent C.M., and Fries C. A rapid and sensitive submicro phosphorous determination. Anal. Chim. Acta 24 (1961) 203-204
33. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
34. Meers P., Ali S., Erukulla R., and Janoff A.S. Novel inner monolayer fusion assays reveal differential monolayer mixing associated with cation-dependent membrane fusion. Biochim. Biophys. Acta 1467 (2000) 227-243
35. Nicol F., Nir S., and Szoka Jr. F.C. Effect of cholesterol and charge on pore formation in bilayer vesicles by a pH-sensitive peptide. Biophys. J. 71 (1996) 3288-3301
36. Vares L., Koulov A.V., and Smith B.D. Highly impermeable vesicles composed of conformationally restricted phosphatidylethanolamine. Chem. Commun. 14 (2002) 1482-1483
37. Aloia R.C., Tian H., and Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5181-5185
38. Raulin J. Human immunodeficiency virus and host cell lipids. Interesting pathways in research for a new HIV therapy. Prog. Lipid Res. 41 (2002) 27-65
39. Liao Z., Cimakasky L.M., Hampton R., Nguyen D.H., and Hildreth J.E.K. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res. Hum. Retroviruses 17 (2001) 1009-1019
40. Sáez-Cirión A., Nir S., Lorizate M., Aguirre A., Cruz A., Pérez-Gil J., and Nieva J.L. Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring. J. Biol. Chem. 277 (2002) 21776-21785
41. Ahn A., Gibbons D.L., and Kielian M. The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domain. J. Virol. 76 (2002) 3267-3275
42. Nguyen D.H., and Hildreth J.E.K. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74 (2000) 3264-3272
43. Sáez-Cirión A., Gómara M.J., Aguirre A., and Nieva J.L. Pre-transmembrane sequence of Ebola glycoprotein Interfacial hydrophobicity distribution and interaction with membranes. FEBS Lett. 533 (2003) 47-53
44. Vincenta N., Genina C., and Malvoisina E. Identification of a conserved domain of the HIV-1 transmembrane protein gp41 which interacts with cholesteryl groups. Biochim. Biophys. Acta 1567 (2002) 157-164
45. Almeida R.F.M., Fedorov A., and Prieto M.J.E. Sphingomyelin-phosphatidylcholine-cholesterol phase diagram: boundaries and composition of lipid rafts. Biophys. J. 85 (2003) 2406-2416
46. Jahn R., and Grubmüller H. Membrane fusion. Curr. Opin. Cell Biol. 14 (2002) 488-495
47. Chernomordik L.V., and Kozlov M.M. Protein-lipid interplay in fusion and fission of biological membranes. Annu. Rev. Biochem. 72 (2003) 175-207
48. Blumenthal R., Clague M.J., Durell S.R., and Epand R.M. Membrane fusion. Chem. Rev. 103 (2003) 53-69
49. Lentz B.R., Malinin V., Haque M.E., and Evans K. Protein machines and lipid assemblies: current views of cell membrane fusion. Curr. Opin. Struct. Biol. 10 (2000) 607-615
50. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., and Matthews T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9770-9774
51. Markosyan R.M., Cohen F.S., and Melikyan G.B. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol. Cell. Biol. 14 (2003) 926-938
52. Melikyan G.B., Markosyan R.M., Hemmati H., Delmedico M.K., Lamber D.M., and Cohen F.S. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. Virology 235 (2000) 118-128
53. Rabenstein M., and Shin Y.K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34 (1995) 13390-13397
54. Salzwedel K., West J.T., and Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for env-mediated fusion and virus infectivity. J. Virol. 73 (1999) 2469-2480
55. Chang D.K., Cheng S.F., and Trivedi V.D. Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1. Implications on viral fusion mechanism. J. Biol. Chem. 274 (1999) 5299-5309